Search

everythinglearnresearchcommunity

for

Search:↓

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Urinary PSA could be an early marker for enlarged prostate.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Early hair loss may indicate prostate issues.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Early balding may be a sign of future prostate problems.

Pumpkin seed oil may improve prostate health, bladder control, and hair growth in men.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

Finasteride 5 mg effectively reduces urinary symptoms and PSA levels in men with enlarged prostates, with few sexual side effects.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Saw palmetto is not proven to improve urinary flow, prostate size, or hair loss.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Testosterone significantly affects urination differences between male and female mice.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Early hair loss may indicate future prostate issues.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Hair loss can be an early sign of prostate enlargement.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.